Protecting against Opioid Prescription-abuse during Prenatal Year Study Act or the POPPY Study Act
This bill requires the Department of Health and Human Services to submit a report to Congress that includes details regarding:
[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5646 Introduced in House (IH)]
<DOC>
115th CONGRESS
2d Session
H. R. 5646
To require the Secretary of Health and Human Services to submit to
Congress a report on opioids prescribing practices for pregnant women.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
April 27, 2018
Mr. Curtis (for himself, Mr. Bishop of Utah, Mr. Stewart, Mr. Diaz-
Balart, and Mrs. Love) introduced the following bill; which was
referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To require the Secretary of Health and Human Services to submit to
Congress a report on opioids prescribing practices for pregnant women.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Protecting against Opioid
Prescription-abuse during Prenatal Year Study Act'' or the ``POPPY
Study Act''.
SEC. 2. REPORT ON OPIOIDS PRESCRIBING PRACTICES FOR PREGNANT WOMEN.
(a) In General.--Not later than 180 days after the date of the
enactment of this Act, the Secretary of Health and Human Services, in
coordination with the Centers for Disease Control and Prevention, the
National Institutes of Health, and the Substance Abuse and Mental
Health Services Administration shall develop and submit to the Congress
a report--
(1) on opioids prescribing practices for pregnant women and
recommendations for such practices;
(2) that provides recommendations for identifying and
reducing opioids misuse during pregnancy;
(3) on prescription opioid misuse during pregnancy in urban
and rural areas;
(4) on prescription opioid use during pregnancy for the
purpose of medication-assisted treatment in urban and rural
areas;
(5) evaluating current utilization of non-opiate pain
management practices in place of prescription opioids during
pregnancy;
(6) providing guidelines encouraging the use of non-opioid
pain management practices during pregnancy when safe and
effective; and
(7) that provides recommendations for increasing public
awareness and education of opioid use disorder in pregnancy,
including available treatment resources in urban and rural
areas.
(b) No Additional Funds.--No additional funds are authorized to be
appropriated for purposes of carrying out subsection (a).
<all>
Introduced in House
Introduced in House
Sponsor introductory remarks on measure. (CR H3710)
Referred to the House Committee on Energy and Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line